ECS Botanics Reports Positive Q4 FY26 Cash Flow
Key points
- Fourth consecutive quarter of positive operating cash flow
- FY26 operating cash flow improves by $5.9 million
- Branded B2C revenue increases by 31% year-on-year
- Expansion into European markets with successful German launch
- Launch of new Australian-grown Terphogz product
Full summary
ECS Botanics Holdings Ltd (ASX:ECS) reported a fourth consecutive quarter of positive operating cash flow, delivering $310k in Q4 FY26 from customer receipts of $5.1 million. The company's FY26 operating cash flow improved by $5.9 million from the $5.1 million outflow in FY25. Customer receipts increased by 12% quarter-on-quarter to $5.1 million. Branded B2C revenue grew 31% year-on-year to $3.45 million, representing 71% of quarterly revenue. FY26 revenue reached approximately $21.0 million, up 8% year-on-year. Cultivation performance improved with a 12% increase in outdoor trimmed flower yield and a 43% rise in PCE production. European expansion advanced with OzSun's initial German shipment selling out quickly and the first Polish product application progressing. ECS launched Gelonoidz #20, the first Australian-grown Terphogz product, expanding its premium branded portfolio. The company ended the quarter with cash of $1.7 million and undrawn corporate loan facilities of $2.8 million, providing total available funding of approximately $4.5 million.
Guidance
FY26 operating cash flow of $788k
Outlook
ECS aims to continue growing branded B2C sales, scale OzSun in Germany, increase export revenue, expand product portfolios, and improve yields and production efficiency in FY27.
Summary generated by a large language model. Please interpret with care.